Top Markets
Coin of the day
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Classement en actions #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Prix de l'action
$25.61
Dernière synchronisation: 2025-10-10
Capitalisation boursière
$1.37B
Changement (1 jour)
0.20%
Changement (1 an)
1.59%
Pays
US
Échange Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Catégorie

Historique du rendement du dividende pour Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Le rendement du dividende (TTM) de Harrow Health, Inc. 8.625% Senior Notes due 2026 (symbole boursier : HROWL) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes